Hypertriglyceridemia: The Most Difficult Lipid Disorder to Evaluate and Treat
Featuring 2015 guest lecturer: Robert H. Eckel, M.D.
Join Providence Portland Medical Foundation in welcoming guest lecturer Robert H. Eckel, M.D., for a discussion on hypertriglyceridemia: the most difficult lipid disorder to evaluate and treat. Dr. Eckel has used translational research to pursue mechanistic relationships between metabolic disorders such as obesity/metabolic syndrome/diabetes and CVD.
Robert H. Eckel, M.D., is the Charles A. Boettcher Endowed Chair in Atherosclerosis and a professor of medicine at the University of Colorado School of Medicine in Denver. Currently, he is a member of the NIH’s Epidemiology of Diabetes Interventions and Complications Observational Safety and Monitoring Board. Dr. Eckel’s translational research has used populations, human subjects in the Clinical Translational Research Center, genetically-modified mice and tissue culture to pursue mechanistic relationships between metabolic disorders such as obesity/metabolic syndrome/diabetes and CVD.
Free AMA PRA credit: challenges of treating lipid disorder, hypertriglyceridemia
Providence Portland Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™.
Admission is free and no registration is required. For more information please call Providence Portland Medical Foundation at 503-215-6186.